Over the years that New Nutrition Business has been tracking the business of food & health we’ve seen plenty of over-hyped “opportunities” come and go - too often taking with them a huge amount of companies’ money (most recently, the plant-based trend).
So to mark our 30th anniversary issue, we departed from our usual format to deliver something a bit different by exploring three opportunities currently being talked up in the industry - Healthy Ageing, GLP-1 and Food as Medicine. Our regular customers liked it so much that we have decided to make it more widely available as a Strategy Briefing.
In Part One we take a hard look at the latest “hot takes” being pushed by consultants and the media to help you determine if they’re right for your business or best avoided. Are Healthy Ageing, GLP-1 and Food as Medicine opportunities for all, opportunities for some, or risky traps that companies should treat with caution?
In Part Two, we go wider. We bring together the key lessons of the last 30 years to set out strategies that anyone can use to be successful, clearly presented so that any business can apply them to any aspect of the nutrition & health marketplace.
Table of Contents
Introduction
Part 1
- Protect your strategy from the hot take trap
- Should we have a Healthy Ageing strategy and what should it look like?
- Should we have a food as medicine strategy? What should our strategy look like?
- What should our strategy for GLP-1 look like?
Part 2
- Seven steps to success for healthier food & beverage brands
- High-risk or low-risk: which route will you choose?
- Seven steps to success for commercialising new ingredients
- What makes some ingredients grow?
- How do we target the right consumer?
